Biopreservation Market to Reach $7.1 Billion by 2029 Driven by Biobanking, Cell & Gene Therapy, and Precision Medicine
The global biopreservation market is experiencing rapid growth as advancements in biotechnology, regenerative medicine, and personalized healthcare increase the demand for reliable biological sample storage solutions. Biopreservation technologies have become indispensable for maintaining the viability, integrity, and functionality of cells, tissues, organs, and other biospecimens used in research, diagnostics, and therapeutic applications.
The biopreservation market was valued at USD 3.7 billion in 2022 and reached approximately USD 4.4 billion in 2024. It is projected to grow at a CAGR of 9.8% from 2024 to 2029, reaching nearly USD 7.1 billion by 2029. Rising investments in biobanking, expanding cell and gene therapy pipelines, growing adoption of precision medicine, and increasing biomedical research activities are among the key factors driving this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=842
Growing Demand for Biopreservation Across Healthcare and Life Sciences
Biopreservation is the process of storing biological materials under carefully controlled conditions to preserve their structural integrity, biological function, and long-term viability. It plays a crucial role in ensuring the quality of samples used for scientific research, clinical diagnostics, drug development, and advanced therapeutic applications.
Today, biopreservation supports a wide range of healthcare and life science fields, including:
- Stem cell research
- Regenerative medicine
- Organ transplantation
- Drug discovery
- Genomics and proteomics
- Personalized medicine
- Clinical research
As biomedical innovation accelerates, preserving high-quality biological samples has become increasingly important for developing next-generation therapies and improving patient outcomes.
Expanding Biobanking Infrastructure Fuels Market Growth
One of the strongest growth drivers for the biopreservation market is the rapid expansion of biobanking infrastructure worldwide.
Biobanks collect, process, and store biological specimens such as blood, tissue, DNA, stem cells, and other biosamples for research and clinical purposes. These repositories support disease research, biomarker discovery, precision medicine initiatives, and pharmaceutical development.
Governments, research institutions, hospitals, and biotechnology companies are investing heavily in modern biobanking facilities equipped with advanced cryogenic storage systems, automated sample management platforms, and digital tracking technologies.
The growing popularity of cord blood banking and stem cell preservation is also contributing significantly to market expansion.
Rising Investments in Biotechnology and Precision Medicine
Healthcare and life science organizations continue increasing investments in biomedical research, creating strong demand for advanced biopreservation solutions.
The growing prevalence of chronic diseases—including cancer, cardiovascular disorders, neurological diseases, and rare genetic conditions—is accelerating research aimed at developing innovative diagnostics and targeted therapies.
At the same time, the adoption of precision medicine is transforming patient care by enabling treatments tailored to individual genetic and molecular profiles.
Effective biopreservation is fundamental to precision medicine because biological samples must retain their integrity throughout collection, storage, transportation, and analysis. Reliable preservation technologies ensure accurate research findings and support personalized treatment strategies.
Cell and Gene Therapy Create Significant Growth Opportunities
The rapidly expanding field of cell and gene therapy represents one of the most promising opportunities for the biopreservation market.
Advanced therapies require highly controlled storage environments throughout manufacturing, transportation, and clinical administration. Maintaining cell viability and product stability is essential to ensuring therapeutic effectiveness and patient safety.
Modern biopreservation technologies support:
- Long-term cell storage
- Cryogenic preservation
- Temperature-controlled transportation
- Product stability monitoring
- Quality assurance throughout the supply chain
As regulatory approvals for cell and gene therapies continue to increase globally, demand for specialized preservation solutions is expected to rise substantially.
Biopreservation Media Lead the Product Segment
Based on product type, biopreservation media account for the largest share of the global market.
These specialized preservation solutions are widely used across research laboratories, hospitals, biotechnology companies, and pharmaceutical organizations to maintain sample stability during storage and transportation.
Biopreservation media offer several important advantages, including:
- Improved cell viability
- Protection against cellular damage
- Enhanced preservation quality
- Reliable sample transport
- Consistent laboratory performance
Their frequent use and recurring purchase requirements contribute to their dominant position within the market.
Meanwhile, the biopreservation equipment segment is expected to witness significant growth, driven by increasing demand for ultra-low temperature freezers, automated storage systems, cryogenic tanks, and advanced monitoring technologies.
Human Tissue Samples Dominate the Biospecimen Segment
Among biospecimen categories, human tissue samples represent the largest market segment.
High-quality preserved tissue samples are essential for numerous biomedical applications, including:
- Cancer research
- Drug development
- Disease modeling
- Genomic analysis
- Proteomics research
- Translational medicine
Researchers depend on advanced preservation systems to maintain tissue integrity and ensure reproducible scientific results.
As clinical research and precision medicine programs continue expanding, demand for reliable tissue preservation technologies is expected to remain strong throughout the forecast period.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=842
Research Applications Continue to Drive Market Expansion
Based on application, research applications account for the largest share of the biopreservation market.
Life science researchers increasingly rely on preserved biological materials for studies involving:
- Stem cell biology
- Regenerative medicine
- Tissue engineering
- Drug discovery
- Organ transplantation research
- Genomic and molecular studies
Advanced biopreservation technologies allow researchers to store biospecimens for extended periods without compromising biological quality, enabling long-term research projects and multicenter collaborations.
Growing investments in biotechnology, pharmaceutical innovation, and academic research continue supporting demand for sophisticated preservation solutions.
Organ Transplantation and Regenerative Medicine Expand Market Potential
The increasing demand for organ transplantation represents another major growth opportunity for the biopreservation industry.
Successful transplantation depends heavily on maintaining organ viability between donor retrieval and recipient implantation. Continuous advancements in cryopreservation, vitrification, and cold-chain logistics are helping extend preservation times while improving transplant success rates.
Similarly, regenerative medicine continues generating demand for advanced preservation technologies that protect engineered tissues, stem cells, and cellular therapies throughout manufacturing and clinical use.
These developments are expected to create significant opportunities for companies specializing in next-generation biopreservation solutions.
Challenges Facing the Biopreservation Market
Despite its strong growth outlook, the biopreservation market faces several operational and technical challenges.
Advanced preservation systems require substantial capital investment, making adoption difficult for smaller healthcare organizations and research institutions.
Key challenges include:
- High equipment and infrastructure costs
- Cryopreservation complexity
- Long-term sample stability concerns
- Cold-chain logistics requirements
- Continuous temperature monitoring
- Regulatory compliance
To address these issues, manufacturers are investing in automation, smart monitoring systems, energy-efficient storage technologies, and cost-effective preservation solutions that improve operational efficiency while maintaining sample quality.
North America Maintains Market Leadership
North America continues to lead the global biopreservation market due to its advanced healthcare infrastructure, strong biotechnology ecosystem, and extensive research investments.
Key factors supporting regional growth include:
- Established biobanking networks
- High adoption of advanced preservation technologies
- Strong government funding
- Growing cell and gene therapy research
- Robust pharmaceutical and biotechnology industries
- Presence of leading market participants
The United States remains the largest contributor to regional demand, supported by continuous investments in biomedical innovation and precision medicine.
Meanwhile, the Asia Pacific region is expected to register the fastest growth over the forecast period as healthcare infrastructure expands, biotechnology investments increase, and research capabilities continue to improve.
Competitive Landscape
The global biopreservation market is highly competitive, with leading companies focusing on product innovation, strategic collaborations, facility expansion, and technological advancements.
Major industry participants include:
- Thermo Fisher Scientific
- Merck KGaA
- PHC Holdings Corporation
- Azenta Inc.
These organizations continue investing in next-generation cryogenic storage systems, automated biobanking solutions, digital sample tracking platforms, and advanced cold-chain technologies to meet the growing demand from healthcare and life science organizations.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=842
Future Outlook
The future of the global biopreservation market remains exceptionally promising as biotechnology, regenerative medicine, and precision healthcare continue transforming modern medicine. Growing reliance on biological samples for diagnostics, therapeutic development, and clinical research is expected to sustain long-term demand for advanced preservation technologies.
Emerging innovations—including automated biobanking, artificial intelligence-enabled sample management, improved cryopreservation techniques, and smart storage systems—will further enhance preservation efficiency and sample quality. As investments in personalized medicine, organ transplantation, and cell and gene therapies continue to rise, the biopreservation market is projected to reach USD 7.1 billion by 2029, creating substantial opportunities for biotechnology companies, research institutions, healthcare providers, and investors across the global life sciences industry.